Merck KGaA - 10%+ Owner at Xilio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
XLO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Merck KGaA since 09 Mar 2025

Holdings reported by Merck KGaA for Xilio Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 680,825 $565,085 $0.8300 26 Oct 2021 Indirect
Series B Preferred Stock 0 26 Oct 2021 Indirect Common Stock
Series C Preferred Srock 0 26 Oct 2021 Indirect Common Stock

Transactions reported by Merck KGaA for Xilio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.